Sales and Marketing

Showing 15 posts of 11527 posts found.

FDA approves GSK cancer drugs

May 30, 2013 Sales and Marketing FDA, GSK

The FDA has approved two of GlaxoSmithKline’s cancer pills: BRAF-inhibitor Tafinlar and the first validated MEK-inhibitor, called Mekinist, both of …

NICE U-turn on Forxiga

May 30, 2013 Sales and Marketing Forxiga, NICE

NICE has recommended Bristol-Myers Squibb and AstraZeneca’s diabetes drug Forxiga in final draft guidance after turning its back on the …

SCM Pharma appoints new director

May 30, 2013 Manufacturing and Production, Research and Development, Sales and Marketing SCM Pharma

UK-based contract development and manufacturing organisation SCM Pharma has strengthened its senior management team by recruiting a director. Paul Bradley …

New HIV pill for UK

May 29, 2013 Sales and Marketing Gilead, HIV, stribild

Gilead Sciences has launched Stribild, a once-daily single tablet regimen to combat HIV – the virus which causes AIDS – …

Amgen moves into Japanese market with Astellas deal

May 29, 2013 Sales and Marketing Amgen, Astellas, Vectibix, Zhejiang

Amgen and Astellas have announced a new collaboration that will see them launch five new medicines in Japan from 2016, …

Diovan trials may have been run by Novartis staff

May 29, 2013 Research and Development, Sales and Marketing Diovan, Novartis

Several post-marketing clinical trials of the blockbuster blood pressure drug Diovan may have been run by employees of the drug’s …

Valeant to buy B+L for $8.7 billion

May 29, 2013 Sales and Marketing B+L, Valeant

Canadian firm Valeant Pharmaceuticals International is to buy Bausch + Lomb in an $8.7 billion deal which will see the …

Xarelto gets ACS indication

May 29, 2013 Sales and Marketing ACS, Bayer, Xarelto

Bayer HealthCare’s bloodthinner Xarelto has expanded its reach in Europe with approval for secondary prevention after an acute coronary syndrome …

Grant NICE greater trial data access – report

May 29, 2013 Research and Development, Sales and Marketing Goldacre, NICE, transparency, trials

A new report by the National Audit Office says NICE should be given greater powers to access clinical trial data. …

Orphan drug for Astellas

May 29, 2013 Sales and Marketing Astellas, Isavuconazole, Orphan

The FDA has granted orphan designation to one of Astellas’ Phase III drugs designed to treat potentially life-threatening fungal infections …

FDA experts recommend Merck sleep pill

May 24, 2013 Research and Development, Sales and Marketing FDA, Merck, insomnia, suvorexant

Merck received welcome news this week from the FDA after one of the US regulator’s expert groups voted to approve …

Janssen outlines pipeline ambitions

May 24, 2013 Research and Development, Sales and Marketing Janssen, Johnson and Johnson, pipeline

Janssen has outlined plans to submit ‘more than ten’ new product filings worldwide in the next four years, along with …

Hurel appoints Schering-Plough executive to its Board

May 24, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Hurel, Merck, Schering-Plough

Pre-clinical products firm Hurel has appointed Dr James MacDonald to the company’s Board of directors.  MacDonald is the former executive …

Positive news for Sanofi asthma drug

May 23, 2013 Sales and Marketing Dupilumab, Regeneron, Sanofi, asthma

An asthma drug being developed by Sanofi and Regeneron Pharmaceuticals has performed well in a Phase IIa trial, reducing the …

Nicholson to step down as NHS leader

May 23, 2013 Sales and Marketing Francis report, Mid Staffs, NHS, Nicholson

Sir David Nicholson is to retire from his post as chief executive of NHS England in March 2014.Sir David has …
The Gateway to Local Adoption Series

Latest content